Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
2.02 USD | +2.54% | +1.51% | +12.22% |
Kurzporträt
Mitarbeiterzahl: 20
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Chief Executive Officer | 51 | 01.05.20 | |
Paul Little
DFI | Director of Finance/CFO | 60 | 15.03.21 |
Steven N. Perrin
PSD | President | 59 | 14.09.20 |
Eliezer Katz
CTO | Chief Tech/Sci/R&D Officer | - | 23.10.23 |
John Herberger
CTO | Chief Tech/Sci/R&D Officer | - | 01.05.22 |
Bryan E. Smith
CMP | Compliance Officer | 45 | 19.04.21 |
David Hovland
LAW | General Counsel | - | 19.04.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Keith Katkin
CHM | Chairman | 52 | 01.05.17 |
Walter C. Ogier
BRD | Director/Board Member | 67 | 14.09.20 |
John S. McBride
BRD | Director/Board Member | 72 | 01.05.17 |
Steven N. Perrin
PSD | President | 59 | 14.09.20 |
Chief Executive Officer | 51 | 01.05.20 | |
James Robinson
BRD | Director/Board Member | 54 | 01.10.23 |
June Lee
BRD | Director/Board Member | 58 | 09.12.20 |
Jan Hillson
BRD | Director/Board Member | 71 | 02.07.21 |
Allan Kirk
BRD | Director/Board Member | - | 02.10.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 110 086 | 0 | 0 | 94,57 % |
Aktie B | 1 | 24 813 130 | 23 466 868 ( 94,57 %) | 0 | |
Aktie C | 0 | 4 422 | 0 | 0 |
Unternehmenskontakt
Sektor
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+12.22% | 48.88 Mio. | |
-2.26% | 104 Mrd. | |
+1.41% | 97.42 Mrd. | |
+0.79% | 22.2 Mrd. | |
-17.84% | 21.23 Mrd. | |
-11.11% | 18.33 Mrd. | |
-42.83% | 16.35 Mrd. | |
-17.63% | 15.06 Mrd. | |
+4.55% | 13.98 Mrd. | |
+32.11% | 11.66 Mrd. |
- Börse
- Aktien
- A2QL00 Aktie
- Unternehmen Eledon Pharmaceuticals, Inc.